Analytical Lens: Exploring Revance Therapeutics Inc (RVNC)’s Financial Story Through Ratios

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Revance Therapeutics Inc (NASDAQ: RVNC) was $5.81 for the day, down -0.68% from the previous closing price of $5.85. In other words, the price has decreased by -$0.68 from its previous closing price. On the day, 5.48 million shares were traded. RVNC stock price reached its highest trading level at $5.905 during the session, while it also had its lowest trading level at $5.74.

Ratios:

Our analysis of RVNC’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.01 and its Current Ratio is at 3.74.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Mizuho on January 29, 2024, Downgraded its rating to Neutral and sets its target price to $9 from $16 previously.

On January 09, 2024, Goldman Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $30 to $8.

Exane BNP Paribas Upgraded its Underperform to Neutral on August 16, 2023, while the target price for the stock was maintained at $20.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 16 ’24 when Jordan Erica sold 2,392 shares for $3.80 per share. The transaction valued at 9,096 led to the insider holds 114,864 shares of the business.

Sjuts Dustin S sold 9,211 shares of RVNC for $46,446 on Mar 18 ’24. The President now owns 167,550 shares after completing the transaction at $5.04 per share. On Mar 18 ’24, another insider, Moxie Dwight, who serves as the CLO & GC of the company, sold 8,125 shares for $5.04 each. As a result, the insider received 40,971 and left with 137,815 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVNC now has a Market Capitalization of 605291584 and an Enterprise Value of 868415552. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.48. Its current Enterprise Value per Revenue stands at 3.457 whereas that against EBITDA is -4.522.

Stock Price History:

Over the past 52 weeks, RVNC has reached a high of $14.24, while it has fallen to a 52-week low of $2.30. The 50-Day Moving Average of the stock is 11.22%, while the 200-Day Moving Average is calculated to be 15.27%.

Shares Statistics:

RVNC traded an average of 4.68M shares per day over the past three months and 6985040 shares per day over the past ten days. A total of 104.18M shares are outstanding, with a floating share count of 95.08M. Insiders hold about 8.74% of the company’s shares, while institutions hold 84.96% stake in the company. Shares short for RVNC as of 1724976000 were 7556918 with a Short Ratio of 1.61, compared to 1722384000 on 15647194. Therefore, it implies a Short% of Shares Outstanding of 7556918 and a Short% of Float of 8.33.

Most Popular